EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 2.651
March 31, 2026 1.670
December 31, 2025 -0.3885
September 30, 2025 -2.128
June 30, 2025 -7.154
March 31, 2025 -8.681
December 31, 2024 -10.69
September 30, 2024 -11.00
June 30, 2024 -11.21
March 31, 2024 -12.62
December 31, 2023 -13.88
September 30, 2023 -16.33
June 30, 2023 -16.82
March 31, 2023 -16.25
December 31, 2022 -15.69
September 30, 2022 -15.99
June 30, 2022 2.263
March 31, 2022 -1.858
December 31, 2021 -3.477
September 30, 2021 -2.214
June 30, 2021 -22.29
March 31, 2021 -20.43
December 31, 2020 -21.23
September 30, 2020 -21.76
June 30, 2020 -22.77
Date Value
March 31, 2020 -24.68
December 31, 2019 -16.03
September 30, 2019 -19.66
June 30, 2019 -18.82
March 31, 2019 -16.09
December 31, 2018 -29.17
September 30, 2018 -28.17
June 30, 2018 -29.80
March 31, 2018 -31.40
December 31, 2017 -24.40
September 30, 2017 -23.40
June 30, 2017 -25.40
March 31, 2017 -25.60
December 31, 2016 -29.40
September 30, 2016 -27.00
June 30, 2016 -20.80
March 31, 2016 -24.80
December 31, 2015 -23.00
September 30, 2015 -27.60
June 30, 2015 -27.00
March 31, 2015 -18.80
December 31, 2014 -13.40
September 30, 2014 -8.40
June 30, 2014 -10.60
March 31, 2014 -16.20

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Iovance Biotherapeutics, Inc. -0.7214
Novavax, Inc. -1.523
Fate Therapeutics, Inc. -1.053
Amgen, Inc. 16.10
Anika Therapeutics, Inc. -0.2741